- Home
- IQV vs DD Comparison
IQV vs DD Comparison
Compare IQV & DD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IQV
- DD
- Stock Information
- Founded
- IQV 1982
- DD 2015
- Country
- IQV United States
- DD United States
- Employees
- IQV N/A
- DD N/A
- Industry
- IQV Biotechnology: Commercial Physical & Biological Resarch
- DD Major Chemicals
- Sector
- IQV Health Care
- DD Industrials
- Exchange
- IQV Nasdaq
- DD Nasdaq
- Market Cap
- IQV 38.1B
- DD 34.8B
- IPO Year
- IQV 2013
- DD N/A
- Fundamental
- Price
- IQV $190.88
- DD $77.53
- Analyst Decision
- IQV Strong Buy
- DD Buy
- Analyst Count
- IQV 16
- DD 13
- Target Price
- IQV $256.27
- DD $93.67
- AVG Volume (30 Days)
- IQV 1.5M
- DD 1.9M
- Earning Date
- IQV 02-12-2025
- DD 02-04-2025
- Dividend Yield
- IQV N/A
- DD 1.96%
- EPS Growth
- IQV 27.98
- DD N/A
- EPS
- IQV 7.62
- DD 1.88
- Revenue
- IQV $15,315,000,000.00
- DD $12,192,000,000.00
- Revenue This Year
- IQV $3.66
- DD $5.75
- Revenue Next Year
- IQV $4.86
- DD $5.16
- P/E Ratio
- IQV $25.21
- DD $41.25
- Revenue Growth
- IQV 3.10
- DD N/A
- 52 Week Low
- IQV $187.62
- DD $61.14
- 52 Week High
- IQV $261.73
- DD $90.06
- Technical
- Relative Strength Index (RSI)
- IQV 32.51
- DD 28.18
- Support Level
- IQV $198.54
- DD $81.53
- Resistance Level
- IQV $201.00
- DD $85.12
- Average True Range (ATR)
- IQV 4.94
- DD 1.33
- MACD
- IQV -0.13
- DD -0.44
- Stochastic Oscillator
- IQV 0.42
- DD 0.07
About IQV IQVIA Holdings Inc.
IQVIA is the result of the 2016 merger of Quintiles, a leading global contract research organization, and IMS Health, a leading healthcare data and analytics provider. The research and development segment focuses primarily on providing outsourced late-stage clinical trials for pharmaceutical, device, and diagnostic firms. The technology and analytics segment provides aggregated information and technology services to clients in the healthcare industry, including pharmaceutical companies, providers, payers, and policymakers, as well as data and analytics capabilities for clinical trials, including virtual trials. The company also has a small contract sales business.
About DD DuPont de Nemours Inc.
DuPont is a diversified global specialty chemicals company created in 2019 as a result of the DowDuPont merger and subsequent separations. Its portfolio includes specialty chemicals and downstream products that serve the electronics, water, construction, safety and protection, automotive, and healthcare industries. DuPont plans to separate the company into three companies going forward, one focused on electronics, one focused on water, and one with more diversified end market exposure. We expect the separations will occur by mid-2026.